International Stem Cell Corporation , a biotechnology company focused on the development of therapeutic products using parthenogenetic stem cells, heralds the recent decision by the German Federal Court of Justice, in the Greenpeace vs Brustle patent case, which may allow ISCO to take a leading position in the European market.
http://www.biospace.com/news_story.aspx?StoryID=281662&full=1
http://www.biospace.com/news_story.aspx?StoryID=281662&full=1
No comments:
Post a Comment